P-652. Evaluation of Empiric Antibiotic Use for Community Acquired Pneumonia

Abstract Background Pneumonia is one of the most common infections resulting in hospitalization. Timely and appropriate empiric antibiotic treatment is crucial to improve prognosis in patients with community-acquired pneumonia (CAP). However, the use of empiric broad spectrum antibiotics is associated with serious consequences including development of antibiotic resistance and unintended adverse drug reactions. The Infectious Diseases Society of America (IDSA) guideline for the treatment of CAP recommends evaluation of specific risk factors to determine the need for empiric broad spectrum antibiotic coverage. The purpose of this study is to evaluate empiric antibiotic adherence to the IDSA CAP guideline. Methods This single center retrospective cohort study evaluated hospitalized adult patients aged 18 years and older who were started on empiric antibiotics for treatment of CAP in the emergency department. Patients were excluded if they were transferred from an outside hospital or were admitted with COVID-19. Baseline characteristics recorded included categorization of non-severe vs severe pneumonia, risk factors for multi-drug resistant organisms, empiric antibiotic therapy, and culture results. The primary outcome evaluated the percentage of patients who received appropriate empiric antibiotic treatment for CAP according to the IDSA guideline. Results A total of 150 patients were included in this study. Approximately 35% of patients presented with severe community acquired pneumonia. The initial antibiotic regimen administered in the emergency department for treatment of suspected CAP was consistent with the IDSA CAP guidelines in 48% of cases. Within twenty-four hours after admission, nearly 25% of cases were optimized to guideline directed therapy. Of the patients with positive culture results, empiric antibiotics were optimized within approximately 48 hours. Conclusion More than half of patients who were started on empiric antibiotics for CAP received broad spectrum antibiotics that were not indicated according to the IDSA guidelines. Most patient’s antibiotic regimen was optimized according to the guidelines within 48 hours. Additional stewardship efforts should be implemented in the emergency department to reduce empiric broad spectrum antibiotic use. Disclosures All Authors: No reported disclosures

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2025-01-29
DOI
https://doi.org/10.1093/ofid/ofae631.849
Primary Topic
Pneumonia and Respiratory Infections
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

P-652. Evaluation of Empiric Antibiotic Use for Community Acquired Pneumonia

Steven Park, Kamryn Plechot, Helen Lee
Open Forum Infectious Diseases
Pneumonia and Respiratory Infections
article

P-652. Evaluation of Empiric Antibiotic Use for Community Acquired Pneumonia

Steven Park, Kamryn Plechot, Helen Lee
article en

Abstract

Abstract Background Pneumonia is one of the most common infections resulting in hospitalization. Timely and appropriate empiric antibiotic treatment is crucial to improve prognosis in patients with community-acquired pneumonia (CAP). However, the use of empiric broad spectrum antibiotics is associated with serious consequences including development of antibiotic resistance and unintended adverse drug reactions. The Infectious Diseases Society of America (IDSA) guideline for the treatment of CAP recommends evaluation of specific risk factors to determine the need for empiric broad spectrum antibiotic coverage. The purpose of this study is to evaluate empiric antibiotic adherence to the IDSA CAP guideline. Methods This single center retrospective cohort study evaluated hospitalized adult patients aged 18 years and older who were started on empiric antibiotics for treatment of CAP in the emergency department. Patients were excluded if they were transferred from an outside hospital or were admitted with COVID-19. Baseline characteristics recorded included categorization of non-severe vs severe pneumonia, risk factors for multi-drug resistant organisms, empiric antibiotic therapy, and culture results. The primary outcome evaluated the percentage of patients who received appropriate empiric antibiotic treatment for CAP according to the IDSA guideline. Results A total of 150 patients were included in this study. Approximately 35% of patients presented with severe community acquired pneumonia. The initial antibiotic regimen administered in the emergency department for treatment of suspected CAP was consistent with the IDSA CAP guidelines in 48% of cases. Within twenty-four hours after admission, nearly 25% of cases were optimized to guideline directed therapy. Of the patients with positive culture results, empiric antibiotics were optimized within approximately 48 hours. Conclusion More than half of patients who were started on empiric antibiotics for CAP received broad spectrum antibiotics that were not indicated according to the IDSA guidelines. Most patient’s antibiotic regimen was optimized according to the guidelines within 48 hours. Additional stewardship efforts should be implemented in the emergency department to reduce empiric broad spectrum antibiotic use. Disclosures All Authors: No reported disclosures

Open Forum Infectious DiseasesVol. 12(Supplement_1)
University of California, Irvine (US), University of California, Irvine Medical Center (US), UC Irvine Health (US)
Openalex Percentile: Top 98%
Pneumonia and Respiratory Infections
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.